Are investors taking a big gamble chasing 4DX shares higher and higher?

4DMedical Ltd (ASX: 4DX) shares have jumped another 8% in Wednesday afternoon trade. At the time of writing, the shares are changing hands at $6 a piece.

Today’s uplift means the shares are now 32% higher for the year-to-date and up an enormous 2,208% over the past 12 months.

The healthcare technology company’s shares have enjoyed an incredible run, but now I’m concerned that investors who are chasing the shares higher and higher could be taking a big gamble.

Why do 4DX shares keep soaring?

4DX is an ASX healthcare technology company that develops imaging software for healthcare providers to analyse airflow through the lungs. It helps identify and treat lung and respiratory diseases ranging from asthma to lung cancer.

The company saw its share price explode in 2025 after its flagship product, CT:VQ, received regulatory approvals. It was quickly implemented and adopted through partnerships and commercial contracts with healthcare organisations.

The company has already signed contracts with hospitals and medical providers across the US. These include Stanford University, the University of Miami, Cleveland Clinic and UC San Diego Health.

It’s this business shift from a research and development business to a globally commercial business which has attracted interest from investors.

There is no price-sensitive news out of the company to explain the share price hike today. 

But it looks like investor interest has continued to keep climbing. 

Here’s why it feels like a gamble

I’m concerned that after such a strong price rally over the past 12 months, the 4DX share price could begin to run away.

While a lot of the price increase is driven by company development and contract wins, it is also being driven by investor expectations and sentiment.

It’s worth remembering that 4DX is still in a loss‑making, growth and commercialisation phase, which means the company is not yet a profitable business.

For the half-year ended 31st December, 4DMedical reported a revenue of $2.9 million, but an adjusted net loss of $16.2 billion, meaning it is far from making money.

This means it also doesn’t pay any dividends to its shareholders.

These types of companies often attract momentum and speculative trading and price increases feed more price increase. Essentially, investor optimism can drive gains.

The problem is that if developments or results don’t live up to expectations, the share price can tumble just as quickly. 

This isn’t to say that could happen. But to assume that it won’t, or that it’ll continue at the same rate, is a gamble I won’t be taking.

The post Are investors taking a big gamble chasing 4DX shares higher and higher? appeared first on The Motley Fool Australia.

More reading

• Why 4DMedical, New Hope, Santos, and St George Mining shares are dropping today
• Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today
• Why 4DMedical, Clinuvel, Life360, and Silex shares are pushing higher today
• Up 2,075% in a year, why is the 4DMedical share price rocketing again on Friday?
• Why is everyone talking about 4DX shares this week?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.